ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2854

Optimizing Data Capture for Performance – Metrics Using Smartphone App Technology

James Willig1, Jeffrey R. Curtis2, Andrew Westfall3, Donald Lein4, Christian Ray Smith4, Jonathan Cortis5, Clayton Rice5 and Christopher Hurt4, 1Med - Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, 2Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, 3Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, 4University of Alabama at Birmingham, Birmingham, AL, 5CTS, Inc, Birmingham, AL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: data collection, performance and technology

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Orthopedics, Low Back Pain and Rehabilitation

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Gait speed has been associated with many clinical outcomes (e.g. frailty, mortality, joint replacement need, etc.) relevant for rheumatologic conditions. Measuring Gait speed (stride length x step count/time) typically requires significant clinician/staff time or a gait lab with specialized equipment. Our formative work was to measure “step count” via smartphones as a first step in making gait speed measurement available for patient home follow-up.

Methods: We developed and tested a mobile App-based method to count steps, comparing a hardware (pedometer) vs. software (“Shake algorithm”) approach. Shake algorithm software allows for adjustment of amplitude (how big a shake equates a step) and refresh rate (how often the software counts a shake/step). We conducted calibration and validation phases. In both, subjects carried iOS and Android phones (one in each front pants pocket) simultaneously, and electronic gait timers measured the time it took to cover pre-measured distances.

Calibration phase: Subjects walked a 20m course at normal and slow (<1.0 m/s) speeds for 9 different shake algorithm settings (x3 walks for each). We determined which setting most closely matched investigator observed step counts. Validation phase: we used the selected shake algorithm settings for the smartphones and recruited subjects to each complete walks (x3) of 6, 10 and 20m at both slow and normal (>1.0m/s) speeds. 

We compared step difference (absolute difference) from observed step counts to hardware (pedometers) and software (shake algorithm) derived step counts. We used generalized estimated equation adjusted (participant level) negative binomial regression models of absolute step difference from observed step counts, to determine optimal settings (calibration) and subsequently to gauge performance of the shake algorithm settings and pedometers across different distances and speeds (validation).

Results: Calibration: 270 observations across 5 individuals were used to determine optimal smartphone shake algorithm settings for slow and fast walking speeds. Validation: Compared to observed step count, the shake service outperformed pedometer across all distances at slow, and at 6m for normal speed on iOS. On the Android phone, the shake service outperformed the pedometer at slow speed for 6 and 20m, and at 20m for normal speed (Table).

Conclusion: Software based approaches such as the shake algorithm, which can have parameters adjusted for optimized measurement of step can be adjusted to outperform fixed hardware such as pedometers. These results will facilitate bringing the capture of performance based metrics such as gait speed to patient home follow-up, using technology users already own (smartphones) to optimize data capture for research and clinical care across rheumatologic conditions.

 

iOS and Android; mean difference between observed & measured step counts across speeds

 

iOS

Slow Speed

(n=153)

P-value

Normal Speed

(n=156)

P-value

 

Shake

Pedometer

Shake

Pedometer

6m

2.16±1.97

8.15±4.48

<0.001

1.93±1.60

5.44±3.82

<0.001

10m

2.85±2.77

5.38±4.84

<0.001

2.48±2.19

2.94±3.37

0.188

20m

5.22±5.22

7.41±7.89

0.029

4.32±3.87

5.24±3.14

0.112

 

Android

Slow Speed

(n=153)

P-value3

Normal Speed

(n=156)

P-value3

 

Shake

Pedometer

 

Shake

Pedometer

 

6m

2.15±1.92

2.92±2.88

0.006

1.79±1.61

1.85±2.28

0.870

10m

2.52±2.50

2.89±3.49

0.374

2.03±2.28

1.47±1.60

0.066

20m

4.34±4.57

3.01±3.78

0.033

3.47±4.41

1.35±1.35

<0.001

 

 

 

 

 

 

 

 

 

 

 

 

 

 



Disclosure: J. Willig, None; J. R. Curtis, AbbVie, Roche/Genentech, BMS, UCB, Myraid, Lilly, Amgen, Janssen, Pfizer, Corrona, 5,Amgen, Pfizer, Crescendo Bio, Corrona, 9; A. Westfall, None; D. Lein, None; C. R. Smith, None; J. Cortis, None; C. Rice, None; C. Hurt, None.

To cite this abstract in AMA style:

Willig J, Curtis JR, Westfall A, Lein D, Smith CR, Cortis J, Rice C, Hurt C. Optimizing Data Capture for Performance – Metrics Using Smartphone App Technology [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/optimizing-data-capture-for-performance-metrics-using-smartphone-app-technology/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/optimizing-data-capture-for-performance-metrics-using-smartphone-app-technology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology